• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与冠心病高血压患者血压控制相关的因素:来自中国胆固醇教育计划的证据。

Factors associated with blood pressure control in hypertensive patients with coronary heart disease: evidence from the Chinese Cholesterol Education Program.

机构信息

Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

出版信息

PLoS One. 2013 May 15;8(5):e63135. doi: 10.1371/journal.pone.0063135. Print 2013.

DOI:10.1371/journal.pone.0063135
PMID:23690989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3655186/
Abstract

Blood pressure (BP) remains poorly controlled among hypertensive patients with coronary heart disease (CHD) in China. Improvement of its management will require an understanding of the patient characteristics and treatment factors associated with uncontrolled hypertension. A cross-sectional survey of 3,279 patients from 52 centers in China was performed to examine potential barriers to adequate blood pressure control of hypertensive patients with CHD. Uncontrolled hypertension was defined as blood pressure ≥130/or 80 mmHg. Multivariable logistic regression was used to identify factors associated with poor blood pressure control. Mean age of the patients was 65 years, 40% were women, and mean BMI was 25 kg/m(2). Mean systolic blood pressure was 136±18 mmHg and mean diastolic blood pressure was 80±11 mmHg. Only 18% of patients had a mean blood pressure <130/80 mmHg during the study period. Multivariate analysis revealed several independent factors of poor blood pressure control: body mass index ≥23 kg/m(2), the presence of stable angina pectoris (SAP), family history of diabetes, and use of calcium channel blockers (CCB). Further analysis showed that non-dihydropyridine calcium antagonist was significantly correlated with low BP control rate. Some of these may be amenable to modification. The results of our study suggest that overweight, the presence of SAP and family history of diabetes are important factors for tight BP control in primary care. In addition, non-dihydropyridine calcium channel blockers appear less effective than other therapies in control of blood pressure and should not be the first choice among hypertensive patients with CHD. Further identification of patients at risk of poor BP control can lead to targeted interventions to improve management.

摘要

在中国,患有冠心病的高血压患者的血压控制仍然很差。改善血压管理需要了解与未控制高血压相关的患者特征和治疗因素。对来自中国 52 个中心的 3279 名患者进行了横断面调查,以检查高血压合并冠心病患者血压控制不理想的潜在障碍。未控制的高血压定义为血压≥130/或 80mmHg。多变量逻辑回归用于确定与血压控制不佳相关的因素。患者的平均年龄为 65 岁,40%为女性,平均 BMI 为 25kg/m2。平均收缩压为 136±18mmHg,平均舒张压为 80±11mmHg。在研究期间,只有 18%的患者平均血压<130/80mmHg。多变量分析显示血压控制不佳的几个独立因素:BMI≥23kg/m2、稳定型心绞痛(SAP)的存在、糖尿病家族史和钙通道阻滞剂(CCB)的使用。进一步分析表明,非二氢吡啶类钙拮抗剂与低血压控制率显著相关。其中一些可能可以改变。我们的研究结果表明,超重、SAP 的存在和糖尿病家族史是基层医疗中严格血压控制的重要因素。此外,非二氢吡啶类钙通道阻滞剂在控制血压方面似乎不如其他治疗方法有效,不应作为高血压合并冠心病患者的首选药物。进一步确定血压控制不佳的患者,可以采取有针对性的干预措施来改善管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c0/3655186/0781a66c6ad6/pone.0063135.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c0/3655186/04814ffd723d/pone.0063135.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c0/3655186/0781a66c6ad6/pone.0063135.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c0/3655186/04814ffd723d/pone.0063135.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c0/3655186/0781a66c6ad6/pone.0063135.g002.jpg

相似文献

1
Factors associated with blood pressure control in hypertensive patients with coronary heart disease: evidence from the Chinese Cholesterol Education Program.与冠心病高血压患者血压控制相关的因素:来自中国胆固醇教育计划的证据。
PLoS One. 2013 May 15;8(5):e63135. doi: 10.1371/journal.pone.0063135. Print 2013.
2
Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.中国高血压伴血脂异常患者降脂治疗过程中的血压和低密度脂蛋白胆固醇控制状况。
Lipids Health Dis. 2019 Jan 29;18(1):32. doi: 10.1186/s12944-019-0974-y.
3
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.2010 加拿大高血压教育计划高血压管理推荐:第 2 部分-治疗。
Can J Cardiol. 2010 May;26(5):249-58. doi: 10.1016/s0828-282x(10)70379-2.
4
HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.土耳其的HYT高血压:关于单独使用钙通道阻滞剂或与其他抗高血压药物联合使用时血压控制情况的横断面调查
High Blood Press Cardiovasc Prev. 2015 Jun;22(2):165-72. doi: 10.1007/s40292-015-0091-6. Epub 2015 Apr 22.
5
Association between blood pressure, the treatment of hypertension, and cardiovascular risk factors in women.女性的血压、高血压治疗与心血管危险因素之间的关联。
J Hypertens. 2000 Jul;18(7):833-41. doi: 10.1097/00004872-200018070-00003.
6
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.2009年加拿大高血压教育计划高血压管理建议:第2部分——治疗
Can J Cardiol. 2009 May;25(5):287-98. doi: 10.1016/s0828-282x(09)70492-1.
7
[Blood pressure control in hypertensive patients with stable coronary heart disease].[稳定型冠心病高血压患者的血压控制]
Arch Mal Coeur Vaiss. 2005 Jul-Aug;98(7-8):795-9.
8
[A cross-sectional study on the treatment goals of blood pressure, serum lipids and blood glucose in elderly patients with coronary heart disease].老年冠心病患者血压、血脂及血糖治疗目标的横断面研究
Zhonghua Yi Xue Za Zhi. 2011 Jun 7;91(21):1479-85.
9
A Combination of Blood Pressure and Total Cholesterol Increases the Lifetime Risk of Coronary Heart Disease Mortality: EPOCH-JAPAN.血压和总胆固醇的联合作用增加了冠心病死亡的终生风险:EPOCH-JAPAN。
J Atheroscler Thromb. 2021 Jan 1;28(1):6-24. doi: 10.5551/jat.52613. Epub 2020 Apr 8.
10
Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry.欧洲心脏病学会 EURoObservational Research Programme 欧洲心血管疾病预防和糖尿病调查中的 24 个欧洲国家冠心病患者的血压分布和控制情况。EUROASPIRE IV 注册研究。
J Hypertens. 2019 Oct;37(10):2015-2023. doi: 10.1097/HJH.0000000000002130.

引用本文的文献

1
Blood pressure control and its associated factors among patients with heart failure in Jordan.约旦心力衰竭患者的血压控制及其相关因素。
J Hum Hypertens. 2023 Nov;37(11):977-984. doi: 10.1038/s41371-023-00807-z. Epub 2023 Feb 11.
2
Socio-demographic, behavioural and clinical factors influencing control of diabetes and hypertension in urban Mysore, South India: a mixed-method study conducted in 2018.影响印度南部迈索尔市城市地区糖尿病和高血压控制的社会人口学、行为和临床因素:2018年开展的一项混合方法研究
Arch Public Health. 2022 Nov 15;80(1):234. doi: 10.1186/s13690-022-00996-y.
3
Disparities in Prevalence and Barriers to Hypertension Control: A Systematic Review.

本文引用的文献

1
Aortic stiffness, blood pressure progression, and incident hypertension.主动脉僵硬度、血压进展与高血压事件。
JAMA. 2012 Sep 5;308(9):875-81. doi: 10.1001/2012.jama.10503.
2
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.美国 1988 年至 2008 年期间不受控制且明显的治疗抵抗性高血压。
Circulation. 2011 Aug 30;124(9):1046-58. doi: 10.1161/CIRCULATIONAHA.111.030189. Epub 2011 Aug 8.
3
Diurnal blood pressure variation, risk categories and antihypertensive treatment.日间血压变化、危险分层与降压治疗。
高血压控制的患病率和障碍差异:系统评价。
Int J Environ Res Public Health. 2022 Nov 6;19(21):14571. doi: 10.3390/ijerph192114571.
4
Factors associated with uncontrolled blood pressure in hypertensive Brazilians.与巴西高血压患者血压控制不佳相关的因素。
J Clin Hypertens (Greenwich). 2022 Jul;24(7):814-824. doi: 10.1111/jch.14501. Epub 2022 Jun 30.
5
Prevalence of risk factors of non-communicable diseases in Kerala, India: results of a cross-sectional study.印度喀拉拉邦非传染性疾病风险因素的患病率:一项横断面研究的结果
BMJ Open. 2019 Nov 10;9(11):e027880. doi: 10.1136/bmjopen-2018-027880.
6
Predictors of poor blood pressure control among Iranian hypertensive patients.伊朗高血压患者血压控制不佳的预测因素。
BMC Res Notes. 2017 Dec 4;10(1):668. doi: 10.1186/s13104-017-2971-4.
Hypertens Res. 2010 Aug;33(8):767-71. doi: 10.1038/hr.2010.111. Epub 2010 Jul 8.
4
Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002.中国高血压的患病率、知晓率、治疗率及控制率:来自2002年中国居民营养与健康状况调查的数据
Circulation. 2008 Dec 16;118(25):2679-86. doi: 10.1161/CIRCULATIONAHA.108.788166.
5
Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry.可改变危险因素的控制及其与冠状动脉搭桥术后1年预后的关系:来自REACH注册研究的见解
Eur Heart J. 2008 Dec;29(24):3052-60. doi: 10.1093/eurheartj/ehn478. Epub 2008 Nov 7.
6
Investigation of blood lipid levels and statin interventions in outpatients with coronary heart disease in China: the China Cholesterol Education Program (CCEP).
Circ J. 2008 Dec;72(12):2040-5. doi: 10.1253/circj.cj-08-0417. Epub 2008 Oct 21.
7
Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.缺血性心脏病预防与管理中的高血压治疗:美国心脏协会高血压研究委员会以及临床心脏病学和流行病学与预防委员会的科学声明
Circulation. 2007 May 29;115(21):2761-88. doi: 10.1161/CIRCULATIONAHA.107.183885. Epub 2007 May 14.
8
The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy.缬沙坦长期抗高血压应用评估(VALUE)试验:接受单一疗法患者的结局
Hypertension. 2006 Sep;48(3):385-91. doi: 10.1161/01.HYP.0000236119.96301.f2. Epub 2006 Jul 24.
9
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.美国心脏病学会/美国心脏协会2005年外周动脉疾病(下肢、肾、肠系膜及腹主动脉)患者管理实践指南:血管外科学会/血管外科学会、心血管造影和介入学会、血管医学和生物学学会、介入放射学会及美国心脏病学会/美国心脏协会实践指南特别工作组(制定外周动脉疾病患者管理指南写作委员会)联合报告;得到美国心血管和肺康复协会、国家心肺血液研究所、血管护理学会、跨大西洋跨学会共识及血管疾病基金会认可。
Circulation. 2006 Mar 21;113(11):e463-654. doi: 10.1161/CIRCULATIONAHA.106.174526.
10
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group.探索心血管疾病的全貌:2003年少数族裔健康峰会:肥胖、代谢综合征与高血压写作小组报告
Circulation. 2005 Mar 15;111(10):e134-9. doi: 10.1161/01.CIR.0000157743.54710.04.